Comparing the current results to its competitors, Sanara Medtech Inc reported Revenue increase in the 2 quarter 2026 by 13.03 % year on year. The sales growth was above Sanara Medtech Inc 's competitors' average revenue growth of 8.1 %, achieved in the same quarter.
Sanara Medtech Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 86.23 %
Sanara Medtech Inc 's Comment on Competition and Industry Peers
The surgical wound care market comprises several large, multi-product companies as well as numerous smaller firms. Products in this market compete with surgical wound irrigation and biomaterial products. Key manufacturers and distributors of competing products include Medline Industries, Inc., Irrimax Corporation, Becton Dickinson and Company, Solventum, and Integra LifeSciences Holdings Corporation. Many competitors in this sector have substantially greater financial and personnel resources.
Inovio Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of immunotherapies for the treatment of various diseases, including cancers and infectious diseases. Their business model involves leveraging their proprietary platforms, such as DNA-based technology and electroporation, to design and develop novel vaccines and therapies which are then advanced through clinical trials and potential partnerships for further commercialization.
Sensus Healthcare Inc operates through a business model centered around the development, manufacturing, and marketing of advanced medical devices, primarily focused on providing non-invasive treatments for various skin conditions and cancers. The company aims to deliver effective and efficient solutions to healthcare providers, enabling them to deliver exceptional patient care and improve outcomes.
Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.
Pulse Biosciences Inc's business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.
Organogenesis Holdings Inc is a regenerative medicine company that specializes in the development and commercialization of advanced wound care and surgical biologic products. Their business model revolves around leveraging their expertise in tissue engineering and biotherapeutics to create innovative products aimed at treating various chronic and acute conditions. Through strategic partnerships, they distribute their products globally to healthcare professionals and patients in need, focusing on improving patient outcomes and quality of life.
Sources:
Sanara Medtech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sanara Medtech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
